Year in review · from our October 2026 register copy
NAFDAC registrations in 2023
By the approval dates our October 2026 copy of the Greenbook records, 2,293 products were approved onto the register in 2023 — 1,779 of them in Drugs. 100% of the class of 2023 is still active in our copy today.
By category
- Drugs— 1,779
- Medical devices— 344
- Vaccines and Biologics— 71
- Veterinary— 60
- Herbals and Nutraceuticals— 32
- Uncategorised— 7
Month by month
Approvals are batched — quiet months and spikes are the register's own rhythm, not demand.
Who registered the most
- 1.Novartis Nigeria— 49 approvals
- 2.Phillips Pharmaceuticals (Nigeria)— 43 approvals
- 3.Emzor Pharmaceutical Industries— 41 approvals
- 4.Krishat Pharma Industries— 36 approvals
- 5.Drugfield Pharmaceuticals— 32 approvals
- 6.Geneith Pharmaceuticals— 30 approvals
- 7.Bioraj Pharmaceuticals— 29 approvals
- 8.Ranbaxy Nigeria— 28 approvals
- 9.Alben Health Care Industries— 26 approvals
- 10.Roche Products— 26 approvals
Where the year's medicines were made
Factory countries recorded on 1,777 of the year's 1,779 drug approvals.
Month-to-month changes — new listings, renewals, lapses — live on the NAFDAC Registry Watch, updated with every register refresh.
Other years
Counted from the approval dates in our dated copy of the public NAFDAC Greenbook. The register backfills approval entries long after the fact, so a year's count can still grow after it ends — which is also why the current year has no page until it completes. Registration counts are not market share or sales.